• Align Technology, Inc. previously announced that Executive Vice President and Chief Legal and Regulatory Officer Julie Coletti will resign effective August 1, 2026, to become Chief Legal Officer at Illumina, Inc.
• This leadership change in a core legal and regulatory role may matter for how investors think about Align’s governance, risk oversight, and long-term execution.
• Next, we’ll examine how the departure of Align’s Chief Legal and Regulatory Officer could shape the company’s broader investment narrative.

Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 29 best rare earth metal stocks of the very few that mine this essential strategic resource.

Align Technology Investment Narrative Recap

To own Align, you really need to believe in the long term potential of Invisalign, iTero and the broader digital orthodontics ecosystem despite softer demand and margin pressure. Right now, the key near term catalyst is better execution on revenue growth and profitability, while the biggest risk remains macro driven weakness in elective dental spending and pricing pressure. Julie Coletti’s planned 2026 departure looks important for governance, but does not appear to materially change those near term drivers today.

Against this backdrop, the most relevant recent development is Align’s broader governance refresh, including the upcoming handoff of the chair role to Kevin Conroy. Combined with the future transition in the Chief Legal and Regulatory Officer position, this points to an evolving oversight framework just as Align is investing in new products like the iTero Lumina scanner and expanded Invisalign indications, which many investors are watching as potential supports for volume and margin trends.

But even if demand for Invisalign holds up better than feared, investors should still be aware of how sustained discounting and lower priced products could...

Align Technology's narrative projects $4.7 billion revenue and $721.2 million earnings by 2029. This requires 4.9% yearly revenue growth and a $291.3 million earnings increase from $429.9 million today.

Uncover how Align Technology's forecasts yield a $209.07 fair value, a 18% upside to its current price.

Exploring Other Perspectives

Some of the lowest estimate analysts were already cautious, assuming only about US$4.5 billion of revenue and US$675.8 million of earnings by 2029, and this leadership change could push their already more pessimistic execution concerns even further, so it is worth comparing those views with more optimistic ones before you decide how you feel about Align’s next chapter.

Explore 6 other fair value estimates on Align Technology - why the stock might be worth as much as 68% more than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Align Technology research is our analysis highlighting 2 key rewards that could impact your investment decision.
• Our free Align Technology research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Align Technology's overall financial health at a glance.

Looking For Alternative Opportunities?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
• Uncover the next big thing with 20 elite penny stocks that balance risk and reward.
• Invest in the nuclear renaissance through our list of 90 elite nuclear energy infrastructure plays powering the global AI revolution.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.